|
Volumn 5, Issue 2, 2015, Pages 102-
|
Drug combo beneficial in colorectal cancer
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBAMIC ACID DERIVATIVE;
CETUXIMAB;
ENCORAFENIB;
MONOCLONAL ANTIBODY;
NVP-BYL719;
SULFONAMIDE;
THIAZOLE DERIVATIVE;
COLORECTAL NEOPLASMS;
ENZYMOLOGY;
GENETICS;
HUMAN;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBAMATES;
COLORECTAL NEOPLASMS;
HUMANS;
SULFONAMIDES;
THIAZOLES;
|
EID: 84942930635
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2014-186 Document Type: Note |
Times cited : (4)
|
References (0)
|